ARCHIVES

PDF file includes 8-page February issue of Business & Regulatory Report.

This article is from The Cancer Letter archive.

Vol. 30 No. 09 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

Exit Joseph Nevins: Duke’s Genomics Luminary Quietly Leaves

October 18, 2013

RFAs available: Chemoprevention Clinical Trials

July 22, 1994

NCI Director Broder’s Year In Review: Avoid Politics, Stay Focused On Science

October 28, 1994

Freestanding Cancer Centers May Be The “Missing Ingredient In Cancer Treatment,” DeVita Believes

January 11, 1985

Center Review By Panel, NCI Leading To Changes; Hammer Tells NCAB It Faces “Difficult Decision”

December 13, 1984

NSABP Sees Groups To Join Breast Cancer Prevention Trial

September 27, 1991